PA8565201A1 - Sistema de suministro osmotico - Google Patents

Sistema de suministro osmotico

Info

Publication number
PA8565201A1
PA8565201A1 PA20038565201A PA8565201A PA8565201A1 PA 8565201 A1 PA8565201 A1 PA 8565201A1 PA 20038565201 A PA20038565201 A PA 20038565201A PA 8565201 A PA8565201 A PA 8565201A PA 8565201 A1 PA8565201 A1 PA 8565201A1
Authority
PA
Panama
Prior art keywords
approximately
weight
osmotic
supply system
coat
Prior art date
Application number
PA20038565201A
Other languages
English (en)
Spanish (es)
Inventor
Michael Christopher Roy
Kenneth Craig Waterman
Anne Martine Billotte
Rebeca Lyn Carrier
Michael Bruce Fergione
Lee Anthony Miller
Sheri Lynn Shamblin
Bruce Clinton Macdonald
Dwayne Thomas Friesen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8565201A1 publication Critical patent/PA8565201A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PA20038565201A 2002-02-01 2003-02-03 Sistema de suministro osmotico PA8565201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35315102P 2002-02-01 2002-02-01

Publications (1)

Publication Number Publication Date
PA8565201A1 true PA8565201A1 (es) 2003-12-10

Family

ID=27663182

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038565201A PA8565201A1 (es) 2002-02-01 2003-02-03 Sistema de suministro osmotico

Country Status (23)

Country Link
US (1) US20030175346A1 (https=)
EP (1) EP1469826B1 (https=)
JP (1) JP2005518418A (https=)
KR (1) KR20040083492A (https=)
CN (1) CN1625388A (https=)
AR (1) AR038373A1 (https=)
AT (1) ATE345776T1 (https=)
BR (1) BR0307320A (https=)
CA (1) CA2474425A1 (https=)
DE (1) DE60309832T2 (https=)
ES (1) ES2277632T3 (https=)
GT (1) GT200300017A (https=)
MX (1) MXPA04007437A (https=)
NO (1) NO20043646L (https=)
NZ (1) NZ533986A (https=)
PA (1) PA8565201A1 (https=)
PE (1) PE20030801A1 (https=)
PL (1) PL372172A1 (https=)
RU (1) RU2004123623A (https=)
TW (1) TW200302748A (https=)
UY (1) UY27644A1 (https=)
WO (1) WO2003063823A2 (https=)
ZA (1) ZA200405406B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US7829507B2 (en) * 2003-09-17 2010-11-09 Halliburton Energy Services Inc. Subterranean treatment fluids comprising a degradable bridging agent and methods of treating subterranean formations
ATE521343T1 (de) * 2004-11-24 2011-09-15 Teva Pharma Im mund zerfallende zusammensetzungen von rasagilin
GB2421431B (en) * 2004-12-24 2007-10-10 Aquasol Ltd Dosing systems
WO2006072878A1 (en) * 2005-01-07 2006-07-13 Ranbaxy Laboratories Limited Oral dosage forms of sertraline having controlled particle size and processes for their preparation
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US8637080B2 (en) * 2007-06-28 2014-01-28 Osmotica Kereskedelmi és Szolgáltató, KFT Rupturing controlled release device comprising a subcoat
RU2589823C2 (ru) * 2009-04-09 2016-07-10 Алкермес Фарма Айэленд Лимитед Композиция для доставки лекарственных средств
SMT202000093T1 (it) 2009-06-16 2020-03-13 Pfizer Forme di dosaggio di apixaban
IT1399240B1 (it) * 2010-03-22 2013-04-11 Trere Chimica S A S Metodo e prodotto per il trattamento di sostanze alcooliche, mosti d'uva e derivati
CN102379858B (zh) * 2011-10-12 2013-06-19 中国药科大学 一种可装载大剂量难溶性药物并促进其吸收的渗透泵片
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
KR102546286B1 (ko) * 2019-11-08 2023-06-22 씨제이제일제당 (주) 눌은 식감을 갖는 전자레인지 조리용 냉동 포장밥

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US64556A (en) * 1867-05-07 Improved belt-punch
US143272A (en) * 1873-09-30 Improvement in saw-sets
US39691A (en) * 1863-08-25 Improvement in pipe-couplings
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4732915A (en) * 1983-11-02 1988-03-22 Alza Corporation Process for increasing solubility of drug
US4610686A (en) * 1983-11-02 1986-09-09 Alza Corporation Controlled delivery of haloperidol by an osmotic delivery system
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
US4627971A (en) * 1985-04-22 1986-12-09 Alza Corporation Osmotic device with self-sealing passageway
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
ATE314054T1 (de) * 1996-10-25 2006-01-15 Shire Lab Inc Osmotisches verabreichungssystem für lösliche dosen
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6485748B1 (en) * 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6156342A (en) * 1998-05-26 2000-12-05 Andex Pharmaceuticals, Inc. Controlled release oral dosage form
US20010031279A1 (en) * 1998-11-02 2001-10-18 Evangeline Cruz Controlled delivery of antidepressants
JP2000171868A (ja) * 1998-12-08 2000-06-23 Canon Inc フィルム送り装置、フィルム使用装置および光学機器
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
WO2001091716A1 (en) * 2000-05-30 2001-12-06 Add Advanced Drug Delivery Technologies Ag Peroral therapeutic system comprising glipizide
IN190699B (https=) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin

Also Published As

Publication number Publication date
DE60309832D1 (de) 2007-01-04
EP1469826B1 (en) 2006-11-22
GT200300017A (es) 2003-09-22
WO2003063823A2 (en) 2003-08-07
TW200302748A (en) 2003-08-16
NZ533986A (en) 2006-03-31
ATE345776T1 (de) 2006-12-15
PE20030801A1 (es) 2003-09-19
RU2004123623A (ru) 2005-04-20
CA2474425A1 (en) 2003-08-07
US20030175346A1 (en) 2003-09-18
DE60309832T2 (de) 2007-10-11
ZA200405406B (en) 2005-07-07
ES2277632T3 (es) 2007-07-16
WO2003063823A3 (en) 2003-12-04
BR0307320A (pt) 2004-12-28
JP2005518418A (ja) 2005-06-23
EP1469826A2 (en) 2004-10-27
MXPA04007437A (es) 2004-10-11
CN1625388A (zh) 2005-06-08
UY27644A1 (es) 2003-09-30
NO20043646L (no) 2004-08-31
KR20040083492A (ko) 2004-10-02
AR038373A1 (es) 2005-01-12
PL372172A1 (en) 2005-07-11

Similar Documents

Publication Publication Date Title
PA8565201A1 (es) Sistema de suministro osmotico
SV2002000250A (es) Formula de dosis de droga accionada por hidrogel ref. pc10818ajtb/bb
ES2073301T3 (es) Composicion multi-capa de liberacion controlada.
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
PE20010053A1 (es) Formulacion de amoxicilina y clavulanato de potasio
AR019507A1 (es) Uso de los inhibidores de cyp2d6 en terapias de combinacion
ES2176209T3 (es) Preparacion farmaceutica oral liberable en el tracto digestivo inferior.
SV2002000586A (es) Formula de dosificacion de la droga accionada por hidrogel ref. pc11095/700006/b
HRP20050340B1 (hr) Sistem za isporuku i postupak za izradu tog sistema za isporuku
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
BG107347A (bg) Висококонцентрирани стабилни разтвори на мелоксикам
MX2009004439A (es) Composicion de ibuprofeno.
NO20080002L (no) Formuleringer av konjugerte ostrogener og bazedoxifen
MX2010002018A (es) Peptido de cdh3 y agente medicinal que comprende al mismo.
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
BRPI0508125A (pt) formulação de alcalóide, método para melhorar a eficácia de um alcalóide, uso do produto da reação de um ou mais alcalóides com um mais derivados de fosfato de um ou mais agentes de transferência de elétrons, junto com excipientes e composição farmacêutica
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
BRPI0415053A (pt) inibidor de p-glicoproteìna, método para preparar o mesmo e composição farmacêutica que compreende o mesmo
GT200600500A (es) Composición farmacéutica orodispersable para la administración oromucosal o sublingual de la agomelatina
DE60235648D1 (de) Pharmazeutische metformintablette mit verlängerter freisetzung
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
AR013967A1 (es) UNA FORMULACION MEDICAMENTOSA PARA LA ADMINISTRACION ORAL DE PELLET DE DIFUSION CONTROLADA QUE TIENE LIBERACION CONTROLADA DE UN COMPUESTO ACTIVO QUE ES SELECCIONADO DEL ACIDO 1-CICLOPROPIL-7- [(S,S)-2,8-DIAZABICICLO [4.3.0] NON-8-IL ]-6-FLuOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLON CARBOXILICO O SALE
AR048531A1 (es) Un sistema de suministro para un agente activo
AR039232A1 (es) Una formulacion farmaceutica que comprende al menos un compuesto seleccionado del grupo formado por hipnoticos no barbituricos y no benzodiacepinicos, y melatonina